Sphera Funds Management Ltd. Protagonist Therapeutics, Inc Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$12.95 - $49.69 $551,488 - $2.12 Million	-42,586 Reduced 14.06%	260,379 $4.61 Million
Q2 2021 Aug 17, 2021	BUY	$25.57 - $44.88 $2.58 Million - $4.53 Million	100,831 Added 49.88%	302,965 $13.6 Million
Q1 2021 May 17, 2021	BUY	$19.02 - $31.15 $3.84 Million - $6.3 Million	202,134 New	202,134 $5.24 Million
Q2 2020 Aug 13, 2020	SELL	$6.19 - $18.84 $3.26 Million - $9.91 Million	-526,075 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$5.4 - $9.22 $561,195 - $958,188	-103,925 Reduced 16.5%	526,075 $3.71 Million
Q4 2019 Feb 13, 2020	BUY	$4.69 - $13.45 $2.95 Million - $8.47 Million	630,000 New	630,000 $4.44 Million

248

56.7M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.04B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.